Evidence map›Paper›PMID 30696872›Full record

ArticleScientific reports2019

Neu-medullocytes, sialidase-positive B cells in the thymus, express autoimmune regulator (AIRE).

Shigeko Kijimoto-Ochiai, Keiko Kamimura, Toshiaki Koda

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Shigeko Kijimoto-OchiaiFaculty of Advanced Life Science, Hokkaido University, N21 W11, Kitaku, Sapporo, 001-0021, Japan. cosmosko060@me.com.
Keiko KamimuraFaculty of Advanced Life Science, Hokkaido University, N21 W11, Kitaku, Sapporo, 001-0021, Japan.
Toshiaki KodaFaculty of Advanced Life Science, Hokkaido University, N21 W11, Kitaku, Sapporo, 001-0021, Japan. t-koda@sci.hokudai.ac.jp.ORCID 0000-0003-1421-6964
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neu-medullocytes, which were previously identified and named by our group, are sialidase (neuraminidase)-positive B cells that express immunoglobulin and Mac-1 in the mouse thymus. Recently, B cells that migrated into the thymus were reported to express autoimmune regulator (AIRE) and to contribute to self-tolerance. We sought to determine whether Neu-medullocytes also express AIRE. We obtained positive results by triple staining Neu-medullocytes for in situ sialidase activity, anti-AIRE, and either anti-IgG or anti-IgM antibodies and observing the staining with confocal microscopy. Additional molecules including CD5, IgM, major histocompatibility complex (MHC) Class II, and neuraminidase 1 (NEU1) were found in sialidase-positive cells independently. The real-time PCR results suggest that the primary sialidase in AIRE-positive cells is neuraminidase 2 (NEU2). Furthermore, some of the AIRE-positive medullary thymic epithelial cells also clearly showed sialidase activity when a triple staining of sialidase activity, anti-AIRE, and Ulex europaeus agglutinin-1 (UEA-1) was performed. Neu-medullocytes may present Aire-dependent antigens for negative selection. We discuss the negative selection steps in consideration of sialidases and sialic acids.

Indexed as

AIRE ProteinAnimalsAutoimmune DiseasesAutoimmunityB-LymphocytesCell DifferentiationCells, CulturedClonal Selection, Antigen-MediatedHumansImmune ToleranceImmunoglobulinsLymphocyte ActivationMiceNeuraminidaseThymus GlandTranscription FactorsAIRE ProteinImmunoglobulinsNeuraminidaseTranscription Factors

Identifiers

PMID30696872
PMCPMC6351566
OpenAlexW2920294825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.